Literature DB >> 22941134

Waist circumference and BMI cut-off points to predict risk factors for metabolic syndrome among outpatients in a district hospital.

Mra Aye1, Malek Sazali.   

Abstract

INTRODUCTION: Metabolic syndrome (MS) is a cluster of risk factors that increases the risk of cardiovascular disease and type 2 diabetes mellitus (DM). Waist circumference (WC), a surrogate indicator of abdominal fat mass, is used to measure central obesity associated with increased risk of hypertension, insulin resistance and type 2 DM, whereas body mass index (BMI) is traditionally used to measure somatic obesity. This study aimed to identify the WC and BMI cut-off points to predict the metabolic risk factors for MS and to determine which is a better predictor.
METHODS: This was a cross-sectional study conducted over a period of six months. The study involved 355 subjects aged 13-91 years. Youden's index was used to identify the optimal cut-off points.
RESULTS: The optimal cut-off point of WC to predict individual metabolic risk in females was 84.5-91.0 cm. The BMI cut-off point to predict hypertension and raised fasting blood sugar was 23.7 kg/m², and that for low level high-density lipoprotein cholesterol was 22.9 kg/m². For males, the corresponding cut-off points were 86.5-91.0 cm for WC and 20.75-25.5 kg/m² for BMI, with corresponding sensitivities and specificities. Area under the curve and the odds of developing individual and ≥ 2 metabolic risk factors for MS were higher for WC than for BMI.
CONCLUSION: WC is a better predictor of metabolic risk factors for developing MS than BMI. Therefore, we propose that metabolic risk factors be screened when WC ≥ 80 cm is found in both genders regardless of BMI.

Entities:  

Mesh:

Year:  2012        PMID: 22941134

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  8 in total

1.  Appropriate body mass index and waist circumference cutoff for overweight and central obesity among adults in Cambodia.

Authors:  Yom An; Siyan Yi; Annette Fitzpatrick; Vinay Gupta; Piseth Raingsey Prak; Sophal Oum; James P Logerfo
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

2.  Using appropriate pre-pregnancy body mass index cut points for obesity in the Chinese population: a retrospective cohort study.

Authors:  Yanxin Wu; Wai-Kit Ming; Dongyu Wang; Haitian Chen; Zhuyu Li; Zilian Wang
Journal:  Reprod Biol Endocrinol       Date:  2018-08-10       Impact factor: 5.211

3.  Exploring the association between thyroid- stimulating hormone and metabolic syndrome: A large population-based study.

Authors:  Yi-Chao Zhou; Wen-Hui Fang; Tung-Wei Kao; Chung-Ching Wang; Yaw-Wen Chang; Tao-Chun Peng; Chen-Jung Wu; Hui-Fang Yang; James Yi-Hsin Chan; Wei-Liang Chen
Journal:  PLoS One       Date:  2018-06-21       Impact factor: 3.240

4.  Circulating microparticle subpopulation in metabolic syndrome: relation to oxidative stress and coagulation markers.

Authors:  Asmaa M Zahran; Sohair K Sayed; Heba A Abd El Hafeez; Walaa A Khalifa; Nahed A Mohamed; Helal F Hetta
Journal:  Diabetes Metab Syndr Obes       Date:  2019-04-12       Impact factor: 3.168

5.  The Relationship between Risk Factors for Metabolic Syndrome and Bone Mineral Density in Menopausal Korean Women.

Authors:  Seok-Hee Kim; Jooyoung Kim
Journal:  Iran J Public Health       Date:  2019-06       Impact factor: 1.429

6.  Correlation between Body Mass Index and Waist Circumference in Patients with Metabolic Syndrome.

Authors:  Marcin Gierach; Joanna Gierach; Marlena Ewertowska; Adam Arndt; Roman Junik
Journal:  ISRN Endocrinol       Date:  2014-03-04

7.  Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study.

Authors:  Maria Angeles Via-Sosa; Cristina Toro; Pere Travé; Marian A March
Journal:  BMC Public Health       Date:  2014-05-22       Impact factor: 3.295

8.  Predictors of metabolic syndrome in community-dwelling older adults.

Authors:  Jeanine M Van Ancum; Nini H Jonkman; Natasja M van Schoor; Emily Tressel; Carel G M Meskers; Mirjam Pijnappels; Andrea B Maier
Journal:  PLoS One       Date:  2018-10-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.